JP2013544276A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544276A5 JP2013544276A5 JP2013541445A JP2013541445A JP2013544276A5 JP 2013544276 A5 JP2013544276 A5 JP 2013544276A5 JP 2013541445 A JP2013541445 A JP 2013541445A JP 2013541445 A JP2013541445 A JP 2013541445A JP 2013544276 A5 JP2013544276 A5 JP 2013544276A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- optionally substituted
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003852 triazoles Chemical class 0.000 claims 2
- -1 (1- (2-aminothiazol-4-yl) -2-(((2S, 3R) -2-((3-((1,5-dihydroxy- 4-oxo-1,4-dihydropyridin-2-yl) methyl) ureido) methyl) -4-oxo-1-sulfoazetidin-3-yl) amino) -2-oxoethylidene) amino Chemical group 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- BKPWVBVFGRYCBH-FMDKYWOUSA-N Nc1nc(/C(/C(N[C@@H]([C@@H](CNC(NCC(N(C=C2O)O)=CC2=O)=O)N2S(O)(=O)=O)C2=O)=O)=N/OC2(CCCC2)C(O)=O)c[s]1 Chemical compound Nc1nc(/C(/C(N[C@@H]([C@@H](CNC(NCC(N(C=C2O)O)=CC2=O)=O)N2S(O)(=O)=O)C2=O)=O)=N/OC2(CCCC2)C(O)=O)c[s]1 BKPWVBVFGRYCBH-FMDKYWOUSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41757510P | 2010-11-29 | 2010-11-29 | |
| US61/417,575 | 2010-11-29 | ||
| PCT/IB2011/055104 WO2012073138A1 (en) | 2010-11-29 | 2011-11-15 | Monobactams |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544276A JP2013544276A (ja) | 2013-12-12 |
| JP2013544276A5 true JP2013544276A5 (enExample) | 2014-12-04 |
| JP5777725B2 JP5777725B2 (ja) | 2015-09-09 |
Family
ID=45315854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013541445A Expired - Fee Related JP5777725B2 (ja) | 2010-11-29 | 2011-11-15 | モノバクタム |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20120302542A1 (enExample) |
| EP (1) | EP2646436B1 (enExample) |
| JP (1) | JP5777725B2 (enExample) |
| KR (1) | KR101514587B1 (enExample) |
| CN (1) | CN103228652B (enExample) |
| AR (1) | AR084001A1 (enExample) |
| AU (1) | AU2011336209B2 (enExample) |
| CA (1) | CA2815821C (enExample) |
| DK (1) | DK2646436T3 (enExample) |
| ES (1) | ES2542431T3 (enExample) |
| IL (1) | IL226052A0 (enExample) |
| MX (1) | MX2013005994A (enExample) |
| SG (1) | SG190007A1 (enExample) |
| TW (1) | TW201247661A (enExample) |
| UY (1) | UY33754A (enExample) |
| WO (1) | WO2012073138A1 (enExample) |
| ZA (1) | ZA201304479B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9988373B2 (en) | 2013-12-26 | 2018-06-05 | Shionogi & Co., Ltd. | Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same |
| CN106164072B (zh) | 2014-03-24 | 2019-10-01 | 诺华股份有限公司 | 用于治疗细菌感染的单环内酰胺有机化合物 |
| ES2817537T3 (es) * | 2015-09-23 | 2021-04-07 | Novartis Ag | Sales y formas sólidas de un antibiótico monobactámico |
| CN105481812B (zh) * | 2015-11-30 | 2020-04-21 | 重庆天奕恒化科技有限公司 | 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法 |
| WO2017106064A1 (en) | 2015-12-15 | 2017-06-22 | Merck Sharp & Dohme Corp. | Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections |
| CA3016341A1 (en) | 2016-03-07 | 2017-09-14 | Merck Sharp & Dohme Corp. | Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections |
| US10047077B2 (en) | 2016-04-13 | 2018-08-14 | Skyline Antiinfectives, Inc. | Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams |
| CN107641119B (zh) | 2016-07-21 | 2019-11-08 | 中国科学院上海药物研究所 | 单环β-内酰胺-铁载体轭合物及其制备方法和用途 |
| ES2912656T3 (es) | 2017-08-02 | 2022-05-26 | Novartis Ag | Proceso para preparar ácido 1-(((Z)-(1-(2-aminotiazol-4-il)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-il)metil)-1-sulfoacetidin-3-il)amino)etiliden)amino)oxi)ciclopropano carboxílico |
| MA50629A (fr) | 2017-10-02 | 2021-03-31 | Merck Sharp & Dohme | Composés monobactames de chromane pour le traitement d'infections bactériennes |
| US10513504B2 (en) | 2018-03-08 | 2019-12-24 | Apotex Inc. | Processes for the preparation of apalutamide and intermediates thereof |
| EP4046998B1 (en) * | 2019-11-22 | 2024-02-28 | Suzhou Erye Pharmaceutical Co., Ltd. | Sulfonylurea ring substituted monocyclic beta-lactam antibiotics |
| MX2022006865A (es) | 2019-12-06 | 2022-07-11 | Vertex Pharma | Tetrahidrofuranos sustituidos como moduladores de canales de sodio. |
| CN111303144B (zh) * | 2019-12-13 | 2020-11-27 | 苏州信诺维医药科技有限公司 | 一种治疗细菌感染的化合物 |
| MX2023011616A (es) | 2021-03-31 | 2023-10-30 | Fedora Pharmaceuticals Inc | Compuestos de lactivicina, su preparacion y uso como agentes antibacterianos. |
| US12528804B2 (en) | 2021-03-31 | 2026-01-20 | Fedora Pharmaceuticals Inc. | Lactivicin compounds, their preparation and use as antibacterial agents |
| WO2022235077A1 (ko) * | 2021-05-07 | 2022-11-10 | 한국생명공학연구원 | 신규 사이드로포어 화합물 및 이를 이용한 금속 나노입자 복합체 |
| CN117794920A (zh) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂 |
| JP7671398B2 (ja) * | 2021-11-18 | 2025-05-01 | メルク・シャープ・アンド・ドーム・エルエルシー | クロマンアミジンモノバクタム抗生物質 |
| PE20241516A1 (es) | 2021-11-18 | 2024-07-19 | Merck Sharp And Dohme Llc | Compuestos monobactamicos de cromano amidina para tratar las infecciones bacterianas |
| JP2025513455A (ja) | 2022-04-22 | 2025-04-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | 疼痛の治療のためのヘテロアリール化合物 |
| CN115304594B (zh) * | 2022-10-12 | 2023-02-14 | 苏州二叶制药有限公司 | 磺酰脲环取代的化合物的盐型及其晶型 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7541487A (en) * | 1986-05-23 | 1987-12-22 | Upjohn Company, The | N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams |
| ATE529111T1 (de) * | 2005-12-07 | 2011-11-15 | Basilea Pharmaceutica Ag | Nützliche monobactam-antibiotika |
| CA2681545C (en) | 2007-03-28 | 2013-10-01 | Apotex Technologies Inc. | Fluorinated derivatives of deferiprone |
| JP2012512863A (ja) | 2008-12-19 | 2012-06-07 | ファイザー・インク | モノカルバム |
-
2011
- 2011-11-15 DK DK11794237.5T patent/DK2646436T3/en active
- 2011-11-15 SG SG2013031752A patent/SG190007A1/en unknown
- 2011-11-15 AU AU2011336209A patent/AU2011336209B2/en not_active Ceased
- 2011-11-15 CA CA2815821A patent/CA2815821C/en not_active Expired - Fee Related
- 2011-11-15 JP JP2013541445A patent/JP5777725B2/ja not_active Expired - Fee Related
- 2011-11-15 CN CN201180057264.5A patent/CN103228652B/zh not_active Expired - Fee Related
- 2011-11-15 KR KR1020137016718A patent/KR101514587B1/ko not_active Expired - Fee Related
- 2011-11-15 EP EP11794237.5A patent/EP2646436B1/en not_active Not-in-force
- 2011-11-15 WO PCT/IB2011/055104 patent/WO2012073138A1/en not_active Ceased
- 2011-11-15 ES ES11794237.5T patent/ES2542431T3/es active Active
- 2011-11-15 MX MX2013005994A patent/MX2013005994A/es active IP Right Grant
- 2011-11-24 TW TW100143172A patent/TW201247661A/zh unknown
- 2011-11-25 AR ARP110104404A patent/AR084001A1/es not_active Application Discontinuation
- 2011-11-28 UY UY0001033754A patent/UY33754A/es not_active Application Discontinuation
- 2011-11-29 US US13/306,581 patent/US20120302542A1/en not_active Abandoned
-
2013
- 2013-02-27 US US13/778,670 patent/US20130252935A1/en not_active Abandoned
- 2013-04-29 IL IL226052A patent/IL226052A0/en unknown
- 2013-06-18 ZA ZA2013/04479A patent/ZA201304479B/en unknown
-
2015
- 2015-01-29 US US14/608,826 patent/US20150148326A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502974A5 (enExample) | ||
| JP2008531599A5 (enExample) | ||
| JP2009531322A5 (enExample) | ||
| JP2013510120A5 (enExample) | ||
| JP2013507434A5 (enExample) | ||
| JP2006524660A5 (enExample) | ||
| JP2009535358A5 (enExample) | ||
| JP2015512931A5 (enExample) | ||
| CA2796967A1 (en) | Heterocyclic derivatives as alk inhibitors | |
| JP2014528464A5 (enExample) | ||
| JP2012512863A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| HRP20170352T1 (hr) | Spojevi bis(fluroalkil)-1,4-benzodiazepinona kao notch inhibitori | |
| JP2016509594A5 (enExample) | ||
| JP2010529147A5 (enExample) | ||
| AR084001A1 (es) | Monobactamas y su uso en el tratamiento de infecciones bacterianas | |
| JP2011500550A5 (enExample) | ||
| JP2012513416A5 (enExample) | ||
| JP2013514367A5 (enExample) | ||
| JP2014500265A5 (enExample) | ||
| JP2015514063A5 (enExample) | ||
| JP2013525286A5 (enExample) | ||
| JP2008534453A5 (enExample) | ||
| JP2011529502A5 (enExample) | ||
| JP2013527847A5 (enExample) |